<DOC>
	<DOCNO>NCT02809937</DOCNO>
	<brief_summary>Delirium frequent postoperative complication . Its occurrence associate bad long-term outcome . In previous randomized control trial , prophylactic low-dose dexmedetomidine infusion early postoperative period decrease incidence delirium elderly patient surgery . The purpose 3-year follow-up study evaluate whether prophylactic low-dose dexmedetomidine infusion improve 3-year outcome elderly patient recruit previous randomize controlled trial .</brief_summary>
	<brief_title>Dexmedetomidine Long-term Outcome Elderly Patients After Surgery</brief_title>
	<detailed_description>Delirium frequent postoperative complication ; systematic review reveal postoperative delirium occur 36.8 % surgical patient , prevalence increase age . The occurrence delirium associate bad long-term outcome include bad functional recovery , decline cognitive function , increase mortality rate . Surgical stress , pain , sleep disturbance important factor lead postoperative delirium elderly . Dexmedetomidine highly selective alpha-2 adrenoreceptor agonist provide anti-anxiety , sedation , modest analgesia minimal respiratory depression . For mechanically ventilate intensive care unit ( ICU ) patient , dexmedetomidine sedation improve quality sleep , decrease incidence delirium , shorten duration ICU stay . For patient undergo surgery , perioperative dexmedetomidine relieve severity stress response , decrease requirement anesthetic , improves postoperative analgesia . In previous stage current study , 700 elderly patient admit ICU noncardiac surgery recruit randomize two group ( dexmedetomidine group placebo [ normal saline ] group ) . The result show prophylactic low-dose dexmedetomidine infusion early postoperative period ameliorate subjective sleep quality decrease incidence delirium ( 22.6 % [ 79/350 ] placebo vs. 9.1 % [ 32/350 ] dexmedetomidine ; Odds Ratio 0.35 , 95 % Confidence Interval 0.22 0.54 ; p &lt; 0.0001 ) . The investigator hypothesize low-dose dexmedetomidine infusion may also improve long-term outcome patient population . The purpose 3-year follow-up study evaluate whether prophylactic low-dose dexmedetomidine infusion early postoperative period improve 3-year outcome elderly patient recruit previous randomize controlled trial .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients include meet follow criterion : 1 . Age 65 year old ; 2 . Underwent elective noncardiac surgery general anesthesia ; 3 . Admitted ICU surgery . Patients exclude meet follow criterion : 1 . Preoperative history schizophrenia , epilepsy , Parkinsonism myasthenia gravis ; 2 . Inability communicate preoperative period ( coma , profound dementia language barrier ) ; 3 . Brain injury neurosurgery ; 4 . Preoperative leave ventricular ejection fraction &lt; 30 % , sick sinus syndrome , severe sinus bradycardia ( &lt; 50 beat per minute ) , seconddegree great atrioventricular block without pacemaker ; 5 . Serious hepatic dysfunction ( ChildPugh class C ) ; 6 . Serious renal dysfunction ( undergoing dialysis surgery ) ; 7 . Unlikely survive 24 hour .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>age</keyword>
	<keyword>surgical procedure , operative</keyword>
	<keyword>delirium</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>long-term outcome</keyword>
</DOC>